AnalystsYi ChenYi Chen's Stock Forecasts
AnalystsYi Chen
Analyst Ranking
Bottom 3%
#4913 out of 5020 analysts
Average Return
-1.52%
Win Rate
38%227 out of 591
Risk vs Reward
Poor
Good
Yi Chen's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Htg Molecular Diagnostics IncHTGMQ | +1,622.56% | $59.04 | $67.80 | 2020-03-25 - 2021-03-26 | Buy |
Eyepoint Pharmaceuticals IncEYPT | +758.90% | $3.26 | $28.00 | 2023-03-02 - 2024-03-01 | Buy |
Eyepoint Pharmaceuticals IncEYPT | +728.74% | $3.34 | $27.68 | 2023-02-27 - 2024-02-28 | Buy |
Eyepoint Pharmaceuticals IncEYPT | +628.98% | $2.83 | $20.63 | 2023-03-26 - 2024-03-26 | Buy |
Kala Bio IncKALA | +332.43% | $4.04 | $17.47 | 2025-05-22 - 2025-09-17 | Buy |
Yi Chen Analyst Color
Get additional color on Yi Chen's coverage of popular stocks
Yi Chen's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Kala Bio IncKALA | 23 | Buy | $35.00 | +100.34% | Maintains | a day ago |
Belite Bio IncBLTE | 21 | Buy | $98.00 | +34.25% | Maintains | 3 days ago |
Tempus Ai IncTEM | 2 | Buy | $98.00 | +13.36% | Maintains | 6 days ago |
Anixa Biosciences IncANIX | 20 | Buy | $7.00 | +108.96% | Reiterates | 7 days ago |
Tourmaline Bio IncTRML | 8 | Hold | $48.00 | +0.63% | Downgrades | 8 days ago |
Regenxbio IncRGNX | 12 | Buy | $34.00 | +276.52% | Reiterates | 10 days ago |
Orchestra Biomed Holdings IncOBIO | 5 | Buy | $10.00 | +306.50% | Maintains | 14 days ago |
Alpha Tau Medical LtdDRTS | 19 | Buy | $9.00 | +134.38% | Reiterates | 15 days ago |
Kiora Pharmaceuticals IncKPRX | 16 | Buy | $10.00 | +277.36% | Reiterates | 16 days ago |
Vivani Medical IncVANI | 7 | Buy | $4.00 | +175.86% | Reiterates | 16 days ago |
Eledon Pharmaceuticals IncELDN | 2 | Buy | $9.00 | +270.37% | Reiterates | 16 days ago |
Oculis Holding AgOCS | 15 | Buy | $33.00 | +89.66% | Maintains | a month ago |
Lipocine IncLPCN | 4 | Buy | $8.00 | +180.70% | Reiterates | a month ago |
Bionano Genomics IncBNGO | 2 | Buy | $11.00 | +521.47% | Maintains | a month ago |
Sanara Medtech IncSMTI | 5 | Buy | $54.00 | +57.94% | Maintains | a month ago |
Icecure Medical LtdICCM | 22 | Buy | $2.00 | +96.08% | Maintains | a month ago |
Harrow IncHROW | 5 | Buy | $64.00 | +48.32% | Maintains | a month ago |
Sensus Healthcare IncSRTS | 17 | Buy | $8.00 | +158.90% | Maintains | a month ago |
Biolife Solutions IncBLFS | 3 | Buy | $32.00 | +25.07% | Maintains | a month ago |
Lifemd IncLFMD | 10 | Buy | $13.00 | +113.82% | Maintains | a month ago |
Eyepoint Pharmaceuticals IncEYPT | 23 | Buy | $23.00 | +68.62% | Maintains | a month ago |
Bausch & Lomb CorpBLCO | 19 | Buy | $16.00 | +5.82% | Maintains | 2 months ago |
Lexaria Bioscience CorpLEXX | 7 | Buy | $4.00 | +230.58% | Maintains | 2 months ago |
Clearside Biomedical IncCLSD | 22 | Hold | $75.00 | +1,977.56% | Downgrades | 2 months ago |
Angiodynamics IncANGO | 11 | Buy | $16.00 | +47.74% | Reiterates | 2 months ago |
Zynex IncZYXI | 22 | Buy | $8.00 | +433.33% | Reiterates | 3 months ago |
Edesa Biotech IncEDSA | 1 | Buy | $5.00 | +109.21% | Assumes | 3 months ago |
Ocular Therapeutix IncOCUL | 23 | Buy | $15.00 | +23.30% | Reiterates | 4 months ago |
Neuropace IncNPCE | 1 | Buy | $18.00 | +82.00% | Initiates Coverage On | 4 months ago |
Caredx IncCDNA | 4 | Hold | $25.00 | +74.83% | Reiterates | 4 months ago |
Okyo Pharma LtdOKYO | 13 | Buy | $7.00 | +228.64% | Reiterates | 4 months ago |
Greenwich Lifesciences IncGLSI | 8 | Buy | $39.00 | +249.78% | Maintains | 5 months ago |
Volitionrx LtdVNRX | 2 | Buy | $2.50 | +303.23% | Reiterates | 5 months ago |
Opko Health IncOPK | 14 | Buy | $3.00 | +115.83% | Reiterates | 5 months ago |
Virax Biolabs Group LtdVRAX | 1 | Buy | $3.00 | +391.80% | Initiates Coverage On | 6 months ago |
Co Diagnostics IncCODX | 17 | Hold | $1.00 | +139.81% | Maintains | 6 months ago |
Barinthus Biotherapeutics PLCBRNS | 20 | Buy | $3.00 | +180.37% | Reiterates | 6 months ago |
Veru IncVERU | 20 | Buy | $30.00 | +777.19% | Reiterates | 9 months ago |
Renalytix PLCRNLXY | 9 | Buy | $3.00 | N/A | Reiterates | a year ago |
Alimera Sciences IncALIM | 16 | Hold | $6.00 | N/A | Downgrades | a year ago |
Applied Dna Sciences IncAPDN | 16 | Buy | $1,125.00 | N/A | Maintains | a year ago |
Genprex IncGNPX | 4 | Buy | $10.00 | N/A | Reiterates | a year ago |
Aslan Pharmaceuticals LtdASLN | 19 | Buy | $72.00 | N/A | Reiterates | a year ago |
Mainz Biomed NvMYNZ | 9 | Buy | $120.00 | N/A | Maintains | 2 years ago |
Prophase Labs IncPRPH | 14 | Buy | $11.00 | N/A | Reiterates | 2 years ago |
Motus Gi Holdings IncMOTS | 8 | Buy | $37.50 | N/A | Reiterates | 2 years ago |
Nemaura Medical IncNMRD | 4 | Buy | $2.50 | N/A | Maintains | 2 years ago |
Opgen IncOPGN | 5 | Buy | $30.00 | N/A | Reiterates | 2 years ago |
Entero Therapeutics IncENTO | 13 | Buy | $200.00 | N/A | Reiterates | 2 years ago |
Centogene NvCNTGF | 8 | Buy | $1.50 | N/A | Reiterates | 2 years ago |
Check Cap LtdCHEK | 6 | Buy | $7.00 | N/A | Reiterates | 2 years ago |
Htg Molecular Diagnostics IncHTGMQ | 10 | Buy | $6.00 | N/A | Reiterates | 2 years ago |
Meridian Bioscience IncVIVO | 7 | Hold | $34.00 | N/A | Downgrades | 3 years ago |
Stealth Biotherapeutics CorpMITO | 3 | Buy | $1.50 | N/A | Maintains | 3 years ago |
Bio Path Holdings IncBPTH | 1 | Buy | $180.00 | N/A | Maintains | 3 years ago |
Dentsply Sirona IncXRAY | 5 | Hold | $48.00 | N/A | Maintains | 3 years ago |
Ortho Clinical Diagnostics Holdings PLCOCDX | 3 | Hold | $24.68 | N/A | Downgrades | 4 years ago |
Interpace Biosciences IncIDXG | 3 | Buy | $9.00 | N/A | Maintains | 4 years ago |
Hyperion Defi IncHYPD | 5 | Buy | $640.00 | N/A | Maintains | 4 years ago |
Celcuity IncCELC | 2 | Buy | $19.00 | N/A | Maintains | 5 years ago |
Cytodyn IncCYDY | 2 | Buy | $4.00 | N/A | Reiterates | 5 years ago |
Oragenics IncOGEN | 1 | Buy | $3,600.00 | N/A | Initiates Coverage On | 6 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.